Patents by Inventor Valeria Raia

Valeria Raia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9730922
    Abstract: There is disclosed a combination of inhibitors of Tissue Transglutaminase (TG2), inhibitors of reactive oxygen species (ROS) and CFTR channel activators (potentiators) for separate, sequential or simultaneous administration to CF patients carrying the ?F508-CFTR mutation, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: August 15, 2017
    Assignee: I.E.R.F.C. Europ. Inst. for Cystic. Fibrosis Res.
    Inventors: Luigi Maiuri, Valeria Raia, Fabio Borella, Guido Kroemer
  • Publication number: 20150328203
    Abstract: There is disclosed a combination of inhibitors of Tissue Transglutaminase (TG2), inhibitors of reactive oxygen species (ROS) and CFTR channel activators (potentiators) for separate, sequential or simultaneous administration to CF patients carrying the ?F508-CFTR mutation, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 4, 2015
    Publication date: November 19, 2015
    Inventors: Luigi MAIURI, Valeria RAIA, Fabio BORELLA, Guido KROEMER
  • Patent number: 9132123
    Abstract: There is disclosed a combination of inhibitors of Tissue Transglutaminase (TG2), inhibitors of reactive oxygen species (ROS) and CFTR channel activators (potentiators) for separate, sequential or simultaneous administration to CF patients carrying the ?F508-CFTR mutation, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: May 16, 2013
    Date of Patent: September 15, 2015
    Assignee: I.E.R.F.C. European Institute For Cystic Fibrosis Research
    Inventors: Luigi Maiuri, Valeria Raia, Fabio Borella, Guido Kroemer